Use of antidepressants and risk of hospitalization for acute myocardial infarction: A nationwide case-crossover study

Journal of Psychiatric Research

Volumn 94, Issue , 2017, Pages 7-14

  Wu, Chi Shin ^a,b,c   Wu, Hsiao Ting ^d   Tsai, Yu Ting ^d   Huang, Ya Wen ^d   Tsai, Hui Ju ^d,e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acute myocardial infarction; Antidepressant use; Case crossover

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUPENTIXOL; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; MOCLOBEMIDE; NORADRENALIN TRANSPORTER; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; ANTIDEPRESSANT AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BINDING AFFINITY; COMORBIDITY; CROSSOVER PROCEDURE; DEPRESSION; DRUG RECEPTOR BINDING; DRUG USE; FEMALE; GENDER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; ACUTE DISEASE; CHEMICALLY INDUCED; HEART INFARCTION; MIDDLE AGED; REGISTER; RISK; STATISTICS AND NUMERICAL DATA; TAIWAN;

ACUTE DISEASE; ADULT; AGED; ANTIDEPRESSIVE AGENTS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK; TAIWAN;

EID: 85020826205     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2017.06.001     Document Type: Article

References (36)

1. Berkman, L.F., Blumenthal, J., Burg, M., Carney, R.M., Catellier, D., Cowan, M.J., Czajkowski, S.M., DeBusk, R., Hosking, J., Jaffe, A., Kaufmann, P.G., Mitchell, P., Norman, J., Powell, L.H., Raczynski, J.M., Schneiderman, N., Enhancing recovery in coronary heart disease patients I. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA 289 (2003), 3106–3116.
2. Blanchette, C.M., Simoni-Wastila, L., Zuckerman, I.H., Stuart, B., A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population. Ann. Epidemiol. 18 (2008), 316–321.
3. Bonnet, F., Irving, K., Terra, J.-L., Nony, P., Berthezène, F., Moulin, P., Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 178 (2005), 339–344.
4. Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 (1987), 373–383.
5. Cheng, C.-L., Lee, C.-H., Chen, P.-S., Li, Y.-H., Lin, S.-J., Yang, Y.-H.K., Validation of acute myocardial infarction cases in the national health insurance research database in taiwan. J. Epidemiol. 24 (2014), 500–507.
6. Cohen, H.W., Gibson, G., Alderman, M.H., Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am. J. Med. 108 (2000), 2–8.
7. Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., Hippisley-Cox, J., Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ, 343, 2011, d4551.
8. Coupland, C., Hill, T., Morriss, R., Moore, M., Arthur, A., Hippisley-Cox, J., Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database. BMJ, 352, 2016, i1350.
9. Glassman, A.H., O'Connor, C.M., Califf, R.M., Swedberg, K., Schwartz, P., Bigger, J.T. Jr., Krishnan, K.R., van Zyl, L.T., Swenson, J.R., Finkel, M.S., Landau, C., Shapiro, P.A., Pepine, C.J., Mardekian, J., Harrison, W.M., Barton, D., McLvor, M., Sertraline antidepressant heart attack randomized Trial G. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002), 701–709.
10. Hippisley-Cox, J., Pringle, M., Hammersley, V., Crown, N., Wynn, A., Meal, A., Coupland, C., Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care. BMJ 323 (2001), 666–669.
11. Kimmel, S.E., Schelleman, H., Berlin, J.A., Oslin, D.W., Weinstein, R.B., Kinman, J.L., Sauer, W.H., Lewis, J.D., The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br. J. Clin. Pharmacol. 72 (2011), 514–517.
12. Maclure, M., The case-crossover design: a method for studying transient effects on the risk of acute events. Am. J. Epidemiol. 133 (1991), 144–153.
13. McCloskey, D.J., Postolache, T.T., Vittone, B.J., Nghiem, K.L., Monsale, J.L., Wesley, R.A., Rick, M.E., Selective serotonin reuptake inhibitors: measurement of effect on platelet function. Transl. Res. 151 (2008), 168–172.
14. Meier, C.R., Schlienger, R.G., Jick, H., Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br. J. Clin. Pharmacol. 52 (2001), 179–184.
15. Monster, T.B., Johnsen, S.P., Olsen, M.L., McLaughlin, J.K., Sorensen, H.T., Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am. J. Med. 117 (2004), 732–737.
16. Nagatomo, T., Rashid, M., Muntasir, H.A., Komiyama, T., Functions of 5-HT 2A receptor and its antagonists in the cardiovascular system. Pharmacol. Ther. 104 (2004), 59–81.
17. Noordam, R., Aarts, N., Leening, M.J., Tiemeier, H., Franco, O.H., Hofman, A., Stricker, B.H., Visser, L.E., Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur. J. Clin. Pharmacol. 72 (2016), 211–218.
18. Penttinen, J., Valonen, P., Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers. Int. J. Epidemiol. 25 (1996), 760–762.
19. Pereira, V.H., Cerqueira, J.J., Palha, J.A., Sousa, N., Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int. J. Cardiol. 166 (2013), 30–37.
20. Pratt, L.A., Ford, D.E., Crum, R.M., Armenian, H.K., Gallo, J.J., Eaton, W.W., Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 94 (1996), 3123–3129.
21. Rademaker, M., Do women have more adverse drug reactions?. Am. J. Clin. Dermatol. 2 (2001), 349–351.
22. Rosengren, A., Hawken, S., Ounpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W.A., Blackett, K.N., Sitthi-amorn, C., Sato, H., Yusuf, S., investigators I. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 953–962.
23. Sauer, W.H., Berlin, J.A., Kimmel, S.E., Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104 (2001), 1894–1898.
24. Sauer, W.H., Berlin, J.A., Kimmel, S.E., Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108 (2003), 32–36.
25. Schins, A., Honig, A., Crijns, H., Baur, L., Hamulyák, K., Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?. Psychosom. Med. 65 (2003), 729–737.
26. Schlienger, R.G., Fischer, L.M., Jick, H., Meier, C.R., Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Saf. 27 (2004), 1157–1165.
27. Smoller, J.W., Allison, M., Cochrane, B.B., Curb, J.D., Perlis, R.H., Robinson, J.G., Rosal, M.C., Wenger, N.K., Wassertheil-Smoller, S., Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch. Intern Med. 169 (2009), 2128–2139.
28. Suissa, S., Delaney, J.A., The case-crossover study design in pharmacoepidemiology. Stat. Methods Med. Res. 18:1 (2008), 53–65.
29. Tata, L.J., West, J., Smith, C., Farrington, P., Card, T., Smeeth, L., Hubbard, R., General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91 (2005), 465–471.
30. Taylor, D., Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatr. Scand. 118 (2008), 434–442.
31. van Melle, J.P., de Jonge, P., Honig, A., Schene, A.H., Kuyper, A.M., Crijns, H.J., Schins, A., Tulner, D., van den Berg, M.P., Ormel, J., investigators M-I. Effects of antidepressant treatment following myocardial infarction. Br. J. Psychiatry 190 (2007), 460–466.
32. Wang, P.S., Schneeweiss, S., Glynn, R.J., Mogun, H., Avorn, J., Use of the case-crossover design to study prolonged drug exposures and insidious outcomes. Ann. Epidemiol. 14 (2004), 296–303.
33. WHO, Collaborating Centre for Drug Statistic Methodology: Guidelines for ATC Classification and DDD Assignment. 2009, WHO, Oslo.
34. Wu, C.-S., Wang, S.-C., Cheng, Y.-C., Gau, S.S.-F., Association of cerebrovascular events with antidepressant use: a case-crossover study. Am. J. Psychiatry, 2011.
35. Wu, C.S., Shau, W.Y., Chan, H.Y., Lai, M.S., Persistence of antidepressant treatment for depressive disorder in Taiwan. Gen. Hosp. Psychiatry 35 (2013), 279–285.
36. Wu, C.-S., Chang, C.-M., Tsai, Y.-T., Huang, Y.-W., Tsai, H.-J., Antipsychotic treatment and the risk of hip fracture in subjects with schizophrenia: a 10-year population-based case-control study. J. Clin. Psychiatry 76 (2015), 1216–1223.